These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 18097369)

  • 41. Regulation of dietary supplement advertising: current claims of interest to the Federal Trade Commission, Food and Drug Administration and National Advertising Division.
    Villafranco JE; Lustigman AB
    Food Drug Law J; 2007; 62(4):709-25. PubMed ID: 18557227
    [No Abstract]   [Full Text] [Related]  

  • 42. Perceived risks and perceived benefits of different nanotechnology foods and nanotechnology food packaging.
    Siegrist M; Stampfli N; Kastenholz H; Keller C
    Appetite; 2008 Sep; 51(2):283-90. PubMed ID: 18406006
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Revisiting Factor VIII cases: is it time for an agency adjudication system?
    Su YC
    Food Drug Law J; 2008; 63(4):943-61. PubMed ID: 19601390
    [No Abstract]   [Full Text] [Related]  

  • 44. Green groups baulk at joining nanotechnology talks.
    Powell K
    Nature; 2004 Nov; 432(7013):5. PubMed ID: 15525946
    [No Abstract]   [Full Text] [Related]  

  • 45. Risks and benefits.
    Nat Nanotechnol; 2006 Dec; 1(3):151. PubMed ID: 18654169
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Don't define nanomaterials.
    Maynard AD
    Nature; 2011 Jul; 475(7354):31. PubMed ID: 21734686
    [No Abstract]   [Full Text] [Related]  

  • 47. Nanotechnology, energy and markets.
    Jones R
    Nat Nanotechnol; 2009 Feb; 4(2):75. PubMed ID: 19197299
    [No Abstract]   [Full Text] [Related]  

  • 48. Are environmental regulations keeping up with innovation? A case study of the nanotechnology industry.
    Fairbrother A; Fairbrother JR
    Ecotoxicol Environ Saf; 2009 Jul; 72(5):1327-30. PubMed ID: 19423165
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Re: introduction to nanotechnology: potential applications in physical medicine and rehabilitation.
    Agoramoorthy G; Chakraborty C
    Am J Phys Med Rehabil; 2007 Dec; 86(12):1031-2; author reply 1032. PubMed ID: 18090446
    [No Abstract]   [Full Text] [Related]  

  • 50. Engineered nanoparticles in consumer products: understanding a new ingredient.
    Kessler R
    Environ Health Perspect; 2011 Mar; 119(3):a120-5. PubMed ID: 21356630
    [No Abstract]   [Full Text] [Related]  

  • 51. Nanotechnology: using co-regulation to bring regulation of modern technologies into the 21st century.
    Reese M
    Health Matrix Clevel; 2013; 23(2):537-72. PubMed ID: 24341081
    [No Abstract]   [Full Text] [Related]  

  • 52. Health-benefit claims for probiotic products.
    Heimbach JT
    Clin Infect Dis; 2008 Feb; 46 Suppl 2():S122-4; discussion S144-51. PubMed ID: 18181716
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nanomaterials and the precautionary principle.
    Elliott KC
    Environ Health Perspect; 2011 Jun; 119(6):A240. PubMed ID: 21628121
    [No Abstract]   [Full Text] [Related]  

  • 54. Correlating physico-chemical with toxicological properties of nanoparticles: the present and the future.
    Rivera Gil P; Oberdörster G; Elder A; Puntes V; Parak WJ
    ACS Nano; 2010 Oct; 4(10):5527-31. PubMed ID: 20973573
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Policy related research: future tasks of the Federal Institute for Risk Assessment].
    Mosbach-Schulz O; Henning KJ; Hensel A
    Berl Munch Tierarztl Wochenschr; 2004; 117(5-6):166-70. PubMed ID: 15188673
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Small world, big hopes.
    Watanabe M
    Nat Mater; 2004 Jan; 3(1):73-4. PubMed ID: 14704788
    [No Abstract]   [Full Text] [Related]  

  • 57. Breaking down biological borders.
    Triendl R
    Nature; 2002 Aug; 418(6899):7. PubMed ID: 12181526
    [No Abstract]   [Full Text] [Related]  

  • 58. US nanotech restructures.
    Nat Mater; 2004 Apr; 3(4):197. PubMed ID: 15057292
    [No Abstract]   [Full Text] [Related]  

  • 59. Nanotechnology and the challenges it poses for the Federal Government.
    Elwood TW
    J Allied Health; 2004; 33(4):227-9. PubMed ID: 15656252
    [No Abstract]   [Full Text] [Related]  

  • 60. Nanotechnology, risk and the environment: a review.
    Hannah W; Thompson PB
    J Environ Monit; 2008 Mar; 10(3):291-300. PubMed ID: 18392270
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.